SpringWorks Therapeutics Inc

NASDAQ:SWTX 1:08:46 PM EDT

22.68

-0.44 (-1.90%)

SpringWorks Therapeutics Inc Stock, NASDAQ:SWTX

100 Washington Boulevard, Stamford, Connecticut 06902

United States of America

Phone: +1.203.883.9490

Number of Employees: 227

http://www.springworkstx.com

Description

Springworks Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the application of a medicine approach to acquiring, developing, and commercializing medicines. Its pipeline includes Nirogacestat, Mirdametinib, BGB-3245 (RAF Fusion and Dimer Inhibitor), SW-682 (TEAD Inhibitor), and EGFR Inhibitor. The company was founded in August 2017 and is headquartered in Stamford, CT.